{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:18Z","timestamp":1790366718682,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015386","name":"The Japan Society for Aeronautical and Space Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023702","name":"Social and Cultural Affairs Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:59:31Z","timestamp":1783353571000},"page":"1840-1849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1001-6298","authenticated-orcid":false,"given":"Rieko","family":"Sagara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-1809","authenticated-orcid":false,"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9925-059X","authenticated-orcid":false,"given":"Shingo","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5847-0596","authenticated-orcid":false,"given":"Kazuyuki","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-5592","authenticated-orcid":false,"given":"Tomoyo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Iwanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-3672","authenticated-orcid":false,"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4294-8030","authenticated-orcid":false,"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Idei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Maruhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.06.021_bib1","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","article-title":"Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis","volume":"266","author":"Cali","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2026.06.021_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.1840070210","article-title":"Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid","volume":"7","author":"Bj\u00f6rkhem","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/brain\/123.5.908","article-title":"Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis","volume":"123","author":"Verrips","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jacl.2026.06.021_bib5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","article-title":"Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey","volume":"18","author":"Pilo-de-la-Fuente","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacl.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","article-title":"A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis","volume":"37","author":"Mignarri","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s10038-017-0389-4","article-title":"Nationwide survey on cerebrotendinous xanthomatosis in Japan","volume":"63","author":"Sekijima","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jacl.2026.06.021_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jacl.2023.09.008","article-title":"A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels","volume":"17","author":"Takahashi","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.06.021_bib9","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/j.jacl.2024.03.004","article-title":"Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols","volume":"18","author":"DeBarber","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.06.021_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.06.021_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(84)90119-0","article-title":"Capillary gas chromatographic determination of cholestanol\/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis)","volume":"137","author":"Koopman","year":"1984","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2026.06.021_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13023-022-02578-1","article-title":"Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis","volume":"18","author":"Pramparo","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1179\/135100007X200173","article-title":"Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress","volume":"12","author":"Gonzalez-Cuyar","year":"2007","journal-title":"Redox Rep"},{"key":"10.1016\/j.jacl.2026.06.021_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-4347(87)80479-6","article-title":"Determination of some hydroxycholesterols in human serum samples","volume":"416","author":"Koopman","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jacl.2026.06.021_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2015.11.015","article-title":"Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry","volume":"1439","author":"Pataj","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jacl.2026.06.021_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100078","article-title":"Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis","volume":"62","author":"H\u00f6flinger","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.06.021_bib17","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1194\/jlr.M060343","article-title":"Cholestane-3\u03b2,5\u03b1,6\u03b2-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency","volume":"56","author":"Pajares","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.06.021_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2012.08.022","article-title":"A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects","volume":"225","author":"Miida","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.06.021_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2013.12.033","article-title":"Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects","volume":"233","author":"Miida","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.06.021_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5551\/jat.40006","article-title":"Homogeneous assays for LDL-C and HDL-C are reliable in both the postprandial and fasting state","volume":"24","author":"Miida","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.06.021_bib21","first-page":"89","article-title":"Simultaneous determination of cholesterol precursors, plant sterols, and oxysterols in plasma using one-round pretreatment","volume":"7","author":"Kuwabara","year":"2023","journal-title":"Medical Mass Spectrometry"},{"key":"10.1016\/j.jacl.2026.06.021_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101449","article-title":"Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): a randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study","volume":"27","author":"Kisanuki","year":"2025","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.jacl.2026.06.021_bib23","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1007\/s10545-008-0963-1","article-title":"Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX","volume":"31","author":"de Sain-van der Velden","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib24","series-title":"Endotext","article-title":"The measurement of lipids, lipoproteins, apolipoproteins, fatty acids, and sterols, and next generation sequencing for the diagnosis and treatment of lipid disorders","author":"Schaefer","year":"2000"},{"key":"10.1016\/j.jacl.2026.06.021_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/00365518809085752","article-title":"Reduced C27-steroid 26-hydroxylase activity in heterozygotes for cerebrotendinous xanthomatosis","volume":"48","author":"Skrede","year":"1988","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jacl.2026.06.021_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF01800057","article-title":"Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands","volume":"11","author":"Koopman","year":"1988","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10545-015-9873-1","article-title":"Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis","volume":"39","author":"Mignarri","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5551\/jat.RV17055","article-title":"Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments","volume":"28","author":"Koyama","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.06.021_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1049850","article-title":"Cerebrotendinous xanthomatosis: a practice review of pathophysiology, diagnosis, and treatment","volume":"13","author":"N\u00f3brega","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jacl.2026.06.021_bib30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","author":"Berginer","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.06.021_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10545-018-0162-7","article-title":"Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes","volume":"41","author":"Amador","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2026.06.021_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0960-8966(00)00112-7","article-title":"Cerebrotendinous xanthomatosis","volume":"10","author":"Verrips","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jacl.2026.06.021_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ecl.2022.02.006","article-title":"The inherited hypercholesterolemias","volume":"51","author":"Loh","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacl.2026.06.021_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-2275(20)38456-X","article-title":"Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans","volume":"29","author":"Kempen","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.06.021_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2013.06.016","article-title":"Ezetimibe decreases serum oxidized cholesterol without impairing bile acid synthesis in Japanese hypercholesterolemic patients","volume":"230","author":"Hirayama","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.06.021_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-2275(20)42083-8","article-title":"High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis","volume":"32","author":"Kuriyama","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.06.021_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.atherosclerosis.2012.09.001","article-title":"Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients","volume":"225","author":"Thongtang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.06.021_bib38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1194\/jlr.P048603","article-title":"On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO","volume":"55","author":"Bj\u00f6rkhem","year":"2014","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:56:01Z","timestamp":1790366161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1933287426004216"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.06.021","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of serum sterols, including oxysterols, for identifying cerebrotendinous xanthomatosis and monitoring treatment efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}